PeptidePedia The community reference

USP General Chapter 71 (revision 4)

Old revision·00:38, 27 Nov 2024·GlossaryGaspar

This is an old revision of this page, as it stood at 00:38, 27 Nov 2024, saved by GlossaryGaspar with the summary state the titration endpoint and the reagent factor. It may differ substantially from the current revision, and any error it contains may since have been corrected.
USP General Chapter 71
TitleSterility Tests
StatusMandatory where referenced
MethodsMembrane filtration; direct inoculation
Topic infobox · conventions

USP General Chapter 71, titled Sterility Tests, prescribes the media, incubation conditions, sample quantities and method-suitability procedures for demonstrating that a sample yields no microbial growth. It is a mandatory chapter where a monograph or regulatory requirement invokes it.[1]

The chapter is explicit that a passing result is not proof of sterility of a batch. Sterility assurance derives from process design and validation; the compendial test is a final check with limited statistical power, and the chapter's companion informational chapter on sterility assurance says so at length.[2]

What the chapter specifies

[edit]

The chapter names two media — fluid thioglycollate medium, incubated at 30–35 °C, and soybean–casein digest medium at 20–25 °C — and requires incubation for not less than fourteen days. It specifies growth-promotion testing of each medium lot against named challenge organisms before use.[1]

Sample quantities are tabulated by container size and batch size. The number of containers tested is small in absolute terms, which is the source of the statistical limitation discussed at Sterility testing.

References

  1. ^ a b United States Pharmacopeia, General Chapter <71>, Sterility Tests.
  2. ^ United States Pharmacopeia, General Chapter <1211>, Sterility Assurance.